Letko, Brosseau & Associates’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.7M Buy
1,617,406
+41,021
+3% +$912K 0.53% 55
2025
Q4
$30.2M Buy
1,576,385
+79,549
+5% +$1.67M 0.49% 56
2025
Q3
$36M Buy
1,496,836
+14,873
+1% +$347K 0.62% 52
2025
Q2
$28.8M Buy
+1,481,963
New +$21.9M 0.55% 51
2023
Q2
Sell
-1,403,273
Closed -$57.5M 95
2023
Q1
$57.5M Buy
+1,403,273
New +$58.6M 1.07% 35
2022
Q3
Sell
-1,582,776
Closed -$46.9M 102
2022
Q2
$46.9M Buy
1,582,776
+63,151
+4% +$2.12M 0.83% 40
2022
Q1
$62M Buy
+1,519,625
New +$65.3M 0.92% 37
2021
Q3
Sell
-1,708,097
Closed -$77.2M 106
2021
Q2
$77.2M Sell
1,708,097
-124,524
-7% -$5.82M 1.03% 35
2021
Q1
$81M Sell
1,832,621
-132,633
-7% -$5.01M 1.11% 33
2020
Q4
$68.3M Sell
1,965,254
-72,346
-4% -$2.04M 0.94% 35
2020
Q3
$35.3M Sell
2,037,600
-196,334
-9% -$3.42M 0.55% 57
2020
Q2
$36.7M Sell
2,233,934
-60,397
-3% -$918K 0.54% 58
2020
Q1
$20.8M Sell
2,294,331
-564,232
-20% -$11.4M 0.36% 60
2019
Q4
$60.7M Sell
2,858,563
-167,690
-6% -$3.72M 0.61% 51
2019
Q3
$69.5M Sell
3,026,253
-71,175
-2% -$1.62M 0.71% 45
2019
Q2
$75.2M Sell
3,097,428
-115,346
-4% -$2.37M 0.76% 45
2019
Q1
$41.6M Buy
3,212,774
+1,005,238
+46% +$17.6M 0.42% 60
2018
Q4
$33.2M Buy
2,207,536
+591,515
+37% +$15.3M 0.37% 62
2018
Q3
$63.5M Buy
1,616,021
+316,789
+24% +$14.3M 0.59% 54
2018
Q2
$63.9M Buy
1,299,232
+239,108
+23% +$13.6M 0.58% 53
2018
Q1
$63.4M Buy
1,060,124
+984,229
+1,297% +$65.7M 0.6% 50
2017
Q4
$5.97M Sell
75,895
-34,848
-31% -$2.81M 0.05% 78
2017
Q3
$9.3M Sell
110,743
-2,486
-2% -$176K 0.08% 76
2017
Q2
$7.4M Sell
113,229
-6,603
-6% -$449K 0.07% 79
2017
Q1
$8.71M Sell
119,832
-12,914
-10% -$848K 0.08% 76
2016
Q4
$7.78M Buy
+132,746
New +$7.01M 0.07% 77

Other funds holding ADNT

Letko, Brosseau & Associates's ADNT Position: Q1 2026 in Review

Letko, Brosseau & Associates increased its Adient (ADNT) stake by 2.6% in Q1 2026, buying an estimated $912K and bringing the position to 1,617,406 shares worth $32.7M. The position accounts for 0.53% of the portfolio, ranked #55.

Letko, Brosseau & Associates first reported a position in ADNT in Q4 2016 and has held it in 26 quarters since. The position peaked at $81M in Q1 2021. 287 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

  • Letko, Brosseau & Associates held 1,617,406 shares of Adient worth $32.7M as of Q1 2026.
  • Letko, Brosseau & Associates bought 41,021 Adient shares in Q1 2026, an estimated $912K.
  • Adient made up 0.53% of Letko, Brosseau & Associates's portfolio in Q1 2026, its #55 holding.
  • Letko, Brosseau & Associates first reported a position in Adient in Q4 2016 and has held it in 26 quarters since.
  • Letko, Brosseau & Associates's Adient position peaked at $81M in Q1 2021.
  • 287 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on Letko, Brosseau & Associates's 13F filing for Q1 2026, filed 12 May 2026.